1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Oh, D. Shin, S.Y. Lee, S. Kim, Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking US Biochemistry BICHAW 0033 0006-2960 39 11855 11864 10.1021/bi000453g 11009597 Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. 2000 10.2210/pdb1f0g/pdb pdb_00001f0g 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2337.998 CECROPIN A-MAGAININ 2 HYBRID PEPTIDE W28L 1 syn polymer no yes KLKLFKKIGIGKFLHSAKKF(NH2) KLKLFKKIGIGKFLHSAKKFX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-06-14 1 1 2008-04-27 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_spectrometer.model _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id RCSB Y RCSB 2000-05-16 REL THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE FOR THIS PEPTIDE IS A HYBRID OF SEQUENCES WHICH OCCUR NATURALLY IN HYALOPHORA CECROPIA (CECROPIA MOTH) AND XENOPUS LAEVIS (AFRICAN CLAWED FROG) sample structures with the lowest energy 50 20 2D NOESY 3.64 298 K Distance Geometry-Dynamical Simulated Annealing Hybrid Method DODECYLPHOSPHOCHOLINE-d38 MICELLES 90% H2O/10% D2O Brunger, A.T. refinement X-PLOR 3.851 400 Bruker AVANCE LYS 1 n 1 LYS 1 A LEU 2 n 2 LEU 2 A LYS 3 n 3 LYS 3 A LEU 4 n 4 LEU 4 A PHE 5 n 5 PHE 5 A LYS 6 n 6 LYS 6 A LYS 7 n 7 LYS 7 A ILE 8 n 8 ILE 8 A GLY 9 n 9 GLY 9 A ILE 10 n 10 ILE 10 A GLY 11 n 11 GLY 11 A LYS 12 n 12 LYS 12 A PHE 13 n 13 PHE 13 A LEU 14 n 14 LEU 14 A HIS 15 n 15 HIS 15 A SER 16 n 16 SER 16 A ALA 17 n 17 ALA 17 A LYS 18 n 18 LYS 18 A LYS 19 n 19 LYS 19 A PHE 20 n 20 PHE 20 A NH2 21 n 21 NH2 21 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 9 A A O H GLY LYS 9 12 1.57 14 A A O H ILE GLY 8 11 1.55 1 A LEU 2 179.59 86.37 2 A LEU 2 62.83 125.53 2 A ILE 10 -89.93 42.06 3 A LEU 2 49.22 81.84 3 A ILE 8 -64.10 -70.59 4 A LEU 2 58.39 119.61 4 A LYS 3 -160.13 46.36 6 A LYS 3 -90.48 35.06 6 A LYS 7 -85.87 35.69 7 A LEU 2 42.90 89.47 9 A LEU 2 56.22 116.40 11 A LEU 2 56.90 117.13 11 A ILE 10 -140.18 28.53 12 A LEU 2 60.55 124.03 13 A LEU 2 59.67 130.22 13 A LYS 3 -109.60 54.88 14 A LEU 4 -91.54 36.92 15 A LEU 2 55.61 -172.90 15 A LYS 19 -143.24 11.28 16 A LYS 3 -153.67 70.19 17 A LEU 2 -57.08 99.15 18 A LEU 2 60.67 121.30 19 A LEU 2 57.16 145.50 20 A ILE 10 -94.16 38.89 Cecropin A(1-8)-magainin 2(1-12) L2 in dodecylphosphocholine micelles 1 N N A LEU 4 A LEU 4 HELX_P A GLY 9 A GLY 9 5 1 6 covale 1.305 both A PHE 20 A C PHE 20 1_555 A NH2 21 A N NH2 21 1_555 ANTIMICROBIAL PROTEIN Helix-Turn-Helix, ANTIMICROBIAL PROTEIN CECA_HYACE UNP 1 P01507 MAGA_XENLA UNP 1 P11006 27 34 1F0G 1 8 P01507 A 1 1 8 83 94 1F0G 9 20 P11006 A 2 9 20 1 TRP engineered mutation LEU 2 1F0G A P01507 UNP 28 2 BINDING SITE FOR RESIDUE NH2 A 21 A NH2 21 Software 2 A ALA 17 A ALA 17 2 1_555 A PHE 20 A PHE 20 2 1_555 1 P 1